Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation solution vs placebo in pediatric lower respiratory tract infection
CTR20180522Phase 3Active
- Sponsor
- Beijing Jiuhuan Huakang Pharmaceutical Technology Center
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, sponsored by Beijing Jiuhuan Huakang Pharmaceutical Technology Center. Started Apr 2018; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20180522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180522.